WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, February 11, 2009, 29(6):1796-1804; doi:10.1523/JNEUROSCI.5729-08.2009

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nikolaeva, M. A.
Right arrow Articles by Stys, P. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nikolaeva, M. A.
Right arrow Articles by Stys, P. K.

 Previous Article  |  Next Article 

Neurobiology of Disease
Effects of the Noradrenergic System in Rat White Matter Exposed to Oxygen–Glucose Deprivation In Vitro

Maria A. Nikolaeva,1 Sandra Richard,1 Abdeslam Mouihate,2 and Peter K. Stys2

1Division of Neuroscience, Ottawa Health Research Institute, University of Ottawa, Ottawa, Ontario, Canada K1Y 4E9, and 2Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada T2N 4N1

Correspondence should be addressed to Peter K. Stys, Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, HRIC 1AA22, 3330 Hospital Drive North West, Calgary, Alberta, Canada T2N 4N1. Email: pstys{at}ucalgary.ca

Norepinephrine (NE) is released in excess into the extracellular space during oxygen–glucose deprivation (OGD) in brain, increasing neuronal metabolism and aggravating glutamate excitoxicity. We used isolated rat optic nerve and spinal cord dorsal columns to determine whether the noradrenergic system influences axonal damage in white matter. Tissue was studied electrophysiologically by recording the compound action potential (CAP) before and after exposure to 60 min of OGD at 36°C. Depleting catecholamine stores with reserpine was protective and improved CAP recovery after 1 h of reperfusion from 17% (control) to 35%. Adding NE during OGD decreased CAP recovery to 8%, and adding NE to reserpine during OGD eliminated the protective effect of the latter. Selective inhibitors of Na+-dependent norepinephrine transport desipramine and nisoxetine improved recovery to 58% and 44%, respectively. {alpha}2 adrenergic receptor agonists UK14,304 and medetomidine improved CAP recovery to 41% and 46% after 1 h of OGD. Curiously, {alpha}2 antagonists alone were also highly protective (e.g., atipamezole: 86% CAP recovery), at concentrations that did not affect baseline excitability. The protective effect of {alpha}2 receptor modulation was corroborated by imaging fluorescent Ca2+ and Na+ indicators within axons during OGD. Both agonists and antagonists significantly reduced axonal Ca2+ and Na+ accumulation in injured axons. These data suggest that the noradrenergic system plays an active role in the pathophysiology of axonal ischemia and that {alpha}2 receptor modulation may be useful against white matter injury.

Key words: axon; ischemia; sodium; calcium; norepinephrine; confocal microscopy


Received Dec. 1, 2008; revised Jan. 4, 2009; accepted Jan. 5, 2009.

Correspondence should be addressed to Peter K. Stys, Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, HRIC 1AA22, 3330 Hospital Drive North West, Calgary, Alberta, Canada T2N 4N1. Email: pstys{at}ucalgary.ca






-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-